Journal of Clinical Oncology (JCO) Podcast

Journal of Clinical Oncology (JCO) Podcast

Author: American Society of Clinical Oncology (ASCO) Language: English Episodes: 100
Hosted by Dr. Davide Soldato, the Journal of Clinical Oncology (JCO) Podcast from the American Society of Clinical Oncology (ASCO) transforms pivotal research into accessible conversation. Each episode focuses directly on a significant study or theme from the latest issue of the Journal of Clinical Oncology, moving from the printed page into a dynamic analysis of what the findings truly mean. Listeners are brought into a detailed scholarly discourse that unpacks methodology, contextualizes results, and debates implications for real-world patient care. This isn't just a summary; it's a critical examination designed for practicing oncologists, fellows, and dedicated healthcare professionals who need to integrate cutting-edge evidence into their daily decisions. The podcast regularly features interviews and in-depth summaries led by the journal's annual fellows, adding fresh, trainee-led perspectives on complex oncology topics. By focusing on the most urgent and practice-changing publications, this podcast serves as an essential audio companion for anyone committed to understanding the rapid evolution of cancer treatment. It’s where rigorous science meets clinical reality, helping the oncology community navigate a constant stream of advancements through informed discussion and expert insight.
Episodes
JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC [not-audio_url] [/not-audio_url]

Duration: 8:56
JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultaneous Publication paper "Neoadjuvant Sacituzumab Govitecan in Patients with Muscle-Invasive Bladder Cancer: Primary…
Adjuvant Durvalumab and the Future of Early-Stage NSCLC [not-audio_url] [/not-audio_url]

Duration: 20:04
Guest Dr. Glenwood Goss and host Dr. Davide Soldato discuss JCO article, "Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer" and the implications of minimal residual disease, results regar…
Infections in Two Diet Strategies in HSCT and Leukemia Patients [not-audio_url] [/not-audio_url]

Duration: 20:40
Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, "Randomized Non-inferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem Cell Transplant and Acute Leukemia Patient…
JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time? [not-audio_url] [/not-audio_url]

Duration: 13:53
In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Fin…